Alan D. Diamond

Array ( [id] => 20451096 [patent_doc_number] => RE050748 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2026-01-06 [patent_title] => Organic electroluminescence device [patent_app_type] => reissue [patent_app_number] => 17/941844 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 15962 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 1868 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19338086 [patent_doc_number] => RE050063 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-07-30 [patent_title] => Fluoropolymer compositions with improved mechanical dampening [patent_app_type] => reissue [patent_app_number] => 17/901938 [patent_app_country] => US [patent_app_date] => 2022-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8704 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19776813 [patent_doc_number] => RE050301 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-02-18 [patent_title] => Depot systems comprising glatiramer or pharmacologically acceptable salt thereof [patent_app_type] => reissue [patent_app_number] => 17/894447 [patent_app_country] => US [patent_app_date] => 2022-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11321 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20546949 [patent_doc_number] => RE050805 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2026-02-24 [patent_title] => Single-layer oral dose of neuro-attenuating ketamine [patent_app_type] => reissue [patent_app_number] => 17/886944 [patent_app_country] => US [patent_app_date] => 2022-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5256 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19665426 [patent_doc_number] => RE050250 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-12-31 [patent_title] => Process for the preparation of cis-alpha,beta substituted cyclopentanones [patent_app_type] => reissue [patent_app_number] => 17/866170 [patent_app_country] => US [patent_app_date] => 2022-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4971 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19622265 [patent_doc_number] => RE050230 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-12-10 [patent_title] => Method of treatment of hypoxia inducible factor (HIF)-related conditions [patent_app_type] => reissue [patent_app_number] => 17/824596 [patent_app_country] => US [patent_app_date] => 2022-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 5283 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19699350 [patent_doc_number] => RE050267 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-01-14 [patent_title] => Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto [patent_app_type] => reissue [patent_app_number] => 17/747917 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 55816 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19592574 [patent_doc_number] => RE050218 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-11-26 [patent_title] => Non-steroidal anti-inflammatory ophthalmic compositions [patent_app_type] => reissue [patent_app_number] => 17/726665 [patent_app_country] => US [patent_app_date] => 2022-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10105 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19309843 [patent_doc_number] => RE050040 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-07-16 [patent_title] => Atropine pharmaceutical compositions [patent_app_type] => reissue [patent_app_number] => 17/685286 [patent_app_country] => US [patent_app_date] => 2022-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11702 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19607633 [patent_doc_number] => RE050227 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-12-03 [patent_title] => Leaching copper-containing ores [patent_app_type] => reissue [patent_app_number] => 17/674546 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7636 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19119508 [patent_doc_number] => RE049935 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-04-23 [patent_title] => Crystalline polymorphs of benfotiamine, process for preparation and its use thereof [patent_app_type] => reissue [patent_app_number] => 17/666352 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 4733 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17666352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19134005 [patent_doc_number] => RE049948 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-04-30 [patent_title] => Aryl ethers and uses thereof [patent_app_type] => reissue [patent_app_number] => 17/592108 [patent_app_country] => US [patent_app_date] => 2022-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 98973 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18993914 [patent_doc_number] => RE049850 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-02-27 [patent_title] => N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds [patent_app_type] => reissue [patent_app_number] => 17/591158 [patent_app_country] => US [patent_app_date] => 2022-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 26372 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591158 [rel_patent_id] =>[rel_patent_doc_number] =>)